Is undetectable prostate-specific antigen always reliable to rule out prostate cancer recurrence after radical prostatectomy?
Standard
Is undetectable prostate-specific antigen always reliable to rule out prostate cancer recurrence after radical prostatectomy? / Schriefer, Philipp; Steurer, Stefan; Huland, Hartwig; Graefen, Markus.
in: J CLIN ONCOL, Jahrgang 30, Nr. 32, 32, 2012, S. 341-344.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Is undetectable prostate-specific antigen always reliable to rule out prostate cancer recurrence after radical prostatectomy?
AU - Schriefer, Philipp
AU - Steurer, Stefan
AU - Huland, Hartwig
AU - Graefen, Markus
PY - 2012
Y1 - 2012
KW - Humans
KW - Male
KW - Aged
KW - Middle Aged
KW - Treatment Outcome
KW - Predictive Value of Tests
KW - Disease Progression
KW - Fatal Outcome
KW - Radiotherapy Dosage
KW - Tomography, X-Ray Computed
KW - Neoplasm Staging
KW - Lymph Node Excision
KW - Tumor Markers, Biological/blood
KW - Prostate-Specific Antigen/blood
KW - Antineoplastic Combined Chemotherapy Protocols/therapeutic use
KW - Neoplasm Grading
KW - Chemoradiotherapy
KW - Biopsy/methods
KW - Prostatectomy/methods
KW - Adenocarcinoma/chemistry/diagnosis/immunology/pathology/therapy
KW - Antigens, Surface/analysis
KW - Bone Neoplasms/secondary
KW - Glutamate Carboxypeptidase II/analysis
KW - Liver Neoplasms/secondary
KW - Lung Neoplasms/secondary
KW - Neoplasm Recurrence, Local/chemistry/diagnosis/immunology/therapy
KW - Phosphopyruvate Hydratase/blood
KW - Prostatic Neoplasms/chemistry/diagnosis/immunology/pathology/therapy
KW - Receptors, Androgen/analysis
KW - Humans
KW - Male
KW - Aged
KW - Middle Aged
KW - Treatment Outcome
KW - Predictive Value of Tests
KW - Disease Progression
KW - Fatal Outcome
KW - Radiotherapy Dosage
KW - Tomography, X-Ray Computed
KW - Neoplasm Staging
KW - Lymph Node Excision
KW - Tumor Markers, Biological/blood
KW - Prostate-Specific Antigen/blood
KW - Antineoplastic Combined Chemotherapy Protocols/therapeutic use
KW - Neoplasm Grading
KW - Chemoradiotherapy
KW - Biopsy/methods
KW - Prostatectomy/methods
KW - Adenocarcinoma/chemistry/diagnosis/immunology/pathology/therapy
KW - Antigens, Surface/analysis
KW - Bone Neoplasms/secondary
KW - Glutamate Carboxypeptidase II/analysis
KW - Liver Neoplasms/secondary
KW - Lung Neoplasms/secondary
KW - Neoplasm Recurrence, Local/chemistry/diagnosis/immunology/therapy
KW - Phosphopyruvate Hydratase/blood
KW - Prostatic Neoplasms/chemistry/diagnosis/immunology/pathology/therapy
KW - Receptors, Androgen/analysis
M3 - SCORING: Journal article
VL - 30
SP - 341
EP - 344
JO - J CLIN ONCOL
JF - J CLIN ONCOL
SN - 0732-183X
IS - 32
M1 - 32
ER -